What are the top six challenges facing pharmaceutical and biopharmaceutical manufacturers in 2022? Find out from four contract manufacturing and development organisations (CDMOs)...

In this on-demand webinar, 908 Devices present a microfluidic capillary zone electrophoresis-based separation coupled with HRAM mass-spectrometry for rapid characterisation of oligos in positive ionisation mode.

Patients treated with Imfinzi and chemotherapy experienced a 20 percent reduction in the risk of death versus chemotherapy alone.

The data adds to the body of evidence relating to the use of Keytruda^® as a monotherapy in second-line HCC post sorafenib.

CME will support the delivery of automated just-in-time clinical supply, as one of the collaborators in the Medicines Manufacturing Innovation Centre Grand Challenge 2.